Search results for "Entera"

showing 10 items of 186 documents

Maggot therapy following orbital exenteration

2007

Orbital exenteration is a radical surgery reserved for the treatment of locally invasive or potentially life-threatening orbital tumours.1 Complications occur after 20–25% of exenterations and include tissue necrosis (6%) and infection (3–4%).2–4 In the present report, we describe the management of a post-exenteration orbital infection by the use of maggots. An 82-year-old multimorbid man presented with a fist-sized painless tumour of the left orbit (fig 1A). Computed tomography demonstrated an orbital mass clearly demarcated from the surrounding tissue (fig 1B). After biopsy, the neoplasm was classified as a borderline-malignant extrapleural solitary fibrous tumour. Therefore, a total orbi…

Malemedicine.medical_specialtygenetic structuresOrbital exenterationCellular and Molecular NeuroscienceBiopsyMaggot therapyOrbital massmedicineAnimalsHumansLettersRadical surgerymusicOrbit EviscerationGram-Positive Bacterial InfectionsAged 80 and overmusic.instrumentmedicine.diagnostic_testbusiness.industrySolitary fibrous tumourBacterial InfectionsOrbit EviscerationBacteroides Infectionseye diseasesSensory SystemsSurgeryOphthalmologyLarvaOrbital NeoplasmsTissue necrosissense organsbusinessEnterococcusBritish Journal of Ophthalmology
researchProduct

Combined medical and mechanical recanalization in acute myocardial infarction

1985

A technique of combined medical and mechanical recanalization was employed in 96 patients with acute transmural myocardial infarction. The mean time between onset of symptoms and admission to hospital was 170 +/- 65 min (X +/- SD). After 10 +/- 16 min, 250,000 U streptokinase was administered intravenously for 20 min. Intracoronary thrombolysis was commenced within 38 +/- 14 min. First coronary angiograms demonstrated reperfusion, an open vessel in 25/96 patients (26%). In 15/71 patients (21%) reperfusion occurred during thrombolysis therapy, before mechanical recanalization could be performed. Recanalization was achieved mechanically in 37/71 patients (52%) with occluded coronary vessels. …

Malemedicine.medical_specialtymedicine.medical_treatmentStreptokinaseMyocardial InfarctionCoronary DiseaseAnterior myocardial infarctionElectrocardiographyRecurrenceCoronary CirculationInternal medicinemedicineHumansInfusions ParenteralStreptokinaseMyocardial infarctionAgedChemotherapybusiness.industryHemodynamicsArrhythmias CardiacStroke VolumeThrombolysisMiddle Agedmedicine.diseaseCombined Modality TherapyMyocardial ContractionPeripheralCoronary vesselCardiologyFemaleCardiology and Cardiovascular MedicinebusinessAngioplasty Balloonmedicine.drugIntracoronary thrombolysisCatheterization and Cardiovascular Diagnosis
researchProduct

New insights into the daily and symbolic use of plants during initial occupations of Formentera (Balearic Islands, Spain)

2021

The island of Formentera, with its small extension and flat orography, was settled relatively late in Mediterranean prehistory between the third and second millennium BC. The sites presented in thi...

Mediterranean climateArcheologyHistoryBalearic islandsEcologyOrographygovernment.political_districtOceanographyFirewoodArchaeologyPrehistoryGeographysoccer.teamBronze AgegovernmentsoccerFormenteraThe Journal of Island and Coastal Archaeology
researchProduct

Aspilota-group (Hymenoptera: Braconidae: Alysiinae) diversity in Mediterranean Natural Parks of Spain

2014

This work analyses the biodiversity of the Aspilota-group (Hymenoptera: Braconidae: Alysiinae) in three Mediterranean Natural parks: Natural Park of La Font Roja, Natural Park of Las Lagunas de la Mata-Torrevieja and Natural Park of La Tinença de Benifassà. Samples were carried out from April 2004 to December 2007. In total, 822 specimens, belonging to 52 species, were collected. Alpha, beta and gamma diversities were analysed, and the Tinença Park was proven to have higher diversity than the Font Roja and Torrevieja. Also, the structure of the Aspilota-group community was analysed.

Mediterranean climateInsectaKulbastaviaBiodiversityBiodiversity: Species Ecosystems & ConservationHymenopteraCarbotripluridaBraconidaeNatural parkBilaterialcsh:QH301-705.5AlysiinaePterygotabiologyEcologyEcologyCenozoicSouthern Europe and MediterraneanCephalornisBiodiversityCircumscriptional namesEuropeIchneumonoideaBoltonocostidaeTiphiinaeCircumscriptional namecommunityValenciaBraconidaeCoelenterataArthropodanatural parksHymenopteridaNephrozoaProtostomiaBasalCircumscriptional names of the taxon underNatural (archaeology)AnimaliaEumetabolaEcology Evolution Behavior and SystematicsAlysiinaeCystomastacoides kiddoAspilotabiology.organism_classificationStrashila incredibilisHymenopteralcsh:Biology (General)NotchiaEcdysozoaTaxonomic Paper
researchProduct

Verwertbarkeit verschiedener Cysteinderivate bei langfristiger parenteraler Ernährung

1989

Utilization of cysteine derivatives for parenteral nutrition was established by means of nitrogen balance of growing rats. N,N-bis-acetylcystine and bisacetyl-glycyl-cystine were not utilized as substrates. N-acetylcysteine, glutathione disulfide, and L-thiazolidine-(4)-carboxylic acid gave evidence as suitable cysteine sources for parenteral nutrition.

Nitrogen balancechemistry.chemical_compoundParenteral nutritionBiochemistryChemistryMedicine (miscellaneous)Glutathione disulfideBiochemistryNitrogen cycleFood ScienceCysteineZeitschrift für Ernährungswissenschaft
researchProduct

Stability of parenteral nutrition admixtures containing organic phosphates

1995

The use of organic phosphates to avoid calcium phosphate precipitation in parenteral nutrition mixtures has been proposed. The purpose of this study was to evaluate the stability of total parenteral nutrition admixtures containing glucose-1-phosphate or glycerol phosphate as the phosphate source over 3 days. Three parenteral nutrition admixtures, each containing glucose-1-phosphate (30.0 mmol), glycerol phosphate (31.4 mmol) or inorganic phosphate (30.0 mmol), and their corresponding aqueous phases were prepared in 3-L ethylene vinyl acetate plastic bags and infusion bottles, and stored at 5 +/- 1 degrees C or 22 +/- 3 degrees C without light protection. Physical stability analysis and samp…

Nutrition and DieteticsAqueous solutionChromatographybusiness.industryPrecipitation (chemistry)Ethylene-vinyl acetateCritical Care and Intensive Care MedicinePhosphatechemistry.chemical_compoundCreamingParenteral nutritionBiochemistrychemistryDynamic light scatteringEmulsionMedicinebusinessClinical Nutrition
researchProduct

Organic phosphates in parenteral nutrition: Pouring fresh water into an old bucket

1996

Nutrition and DieteticsParenteral nutritionAnimal scienceOrganic phosphatesFresh waterbusiness.industryEndocrinology Diabetes and MetabolismEnvironmental chemistryMedicinebusinessFat emulsionInfant newbornNutrition
researchProduct

Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.

2014

Objective To analyze the feasibility of laparoscopic/robotic secondary cytoreductive surgery and hyperthermic intraperitoneal intra-operative chemotherapy (SCS + HIPEC) in a retrospective series of isolated platinum sensitive recurrent ovarian cancer. Methods We retrospectively evaluated a consecutive series of ovarian cancer patients with isolated platinum sensitive relapse. Isolated relapse was defined as the presence of a single nodule, in a single anatomic site. In all cases the presence of isolated relapse was assessed at pre-operative FDG-PET/CT scan, and confirmed with staging laparoscopy performed immediately before SCS + HIPEC. Results 84 women with platinum sensitive relapse recei…

OVARIAN CANEROrganoplatinum Compoundsmedicine.medical_treatmentdrug therapy/pathology/surgery/therapyCarcinoma Ovarian EpithelialMultimodal ImagingCohort StudiesObstetrics and gynaecologyNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsInfusions ParenteralNeoplasms Glandular and EpithelialLaparoscopyadministration /&/ dosageTomographyRandomized Controlled Trials as TopicOvarian Neoplasmsmedicine.diagnostic_testObstetrics and GynecologyGlandular and EpithelialMiddle AgedDebulkingCombined Modality TherapyIsolated platinum sensitive relapseX-Ray ComputedOxaliplatinPhase III as TopicOncologyFemalediagnostic usemedicine.drugmedicine.medical_specialtyInfusionsAged Antineoplastic Combined Chemotherapy Protocols; administration /&/ dosage Cisplatin; administration /&/ dosage Clinical Trials; Phase II as Topic Clinical Trials; Phase III as Topic Cohort Studies Combined Modality Therapy Female Fluorodeoxyglucose F18; diagnostic use Humans Hyperthermia; Induced; methods Infusions; Parenteral Middle Aged Minimally Invasive Surgical Procedures Multimodal Imaging Neoplasms; Glandular and Epithelial; drug therapy/pathology/surgery/therapy Organoplatinum Compounds; administration /&/ dosage Ovarian Neoplasms; drug therapy/pathology/surgery/therapy Positron-Emission Tomography Radiopharmaceuticals; diagnostic use Randomized Controlled Trials as Topic Retrospective Studies Tomography; X-Ray Computed ocal; pathologyocalmethodsClinical Trials Phase II as TopicMinimally invasive surgeryOvarian cancerFluorodeoxyglucose F18ParenteralmedicineHumansMinimally Invasive Surgical ProceduresClinical TrialsHyperthermiaAgedRetrospective StudiesCisplatinChemotherapySeries (stratigraphy)HIPECbusiness.industryPhase II as TopicInducedHyperthermia Inducedmedicine.diseaseOxaliplatinSurgeryRoboticSettore MED/40 - GINECOLOGIA E OSTETRICIAClinical Trials Phase III as TopicPositron-Emission TomographyLaparoscopypathologyNeoplasm Recurrence LocalCisplatinRadiopharmaceuticalsbusinessOvarian cancerTomography X-Ray Computed
researchProduct

Survival after curative pelvic exenteration for primary or recurrent cervical cancer a retrospective multicentric study of 167 patients

2014

ObjectiveEvaluate the survival of patients who underwent pelvic exenteration (PE) with curative intent for primary persistent or recurrent cervical cancer.MethodsWe retrospectively investigated 167 consecutive patients, referred to the gynecological oncology units of 4 centers in Germany or Italy, who underwent PE. Data regarding surgery, histology, and oncologic outcomes were collected and statistically evaluated. Survival was determined from the day of exenteration until last follow-up or death.ResultsThe median age was 51 years. Twenty-seven patients (16.2%) underwent PE owing to advanced primary tumors (group A), 34 patients (20.4%) underwent PE owing to persistent cancer after chemothe…

OncologyUterine Cervical NeoplasmSurvivalmedicine.medical_treatmentUterine Cervical NeoplasmsRetrospective StudieLymph nodeCervical cancerAged 80 and overMedicine (all)Obstetrics and GynecologyMiddle AgedPrognosisCombined Modality TherapySurvival Ratemedicine.anatomical_structureOncologyLymphatic MetastasisCarcinoma Squamous CellAdenocarcinomaFemaleHumanAdultmedicine.medical_specialtyPrognosiAdenocarcinomaFollow-Up StudieYoung AdultInternal medicinemedicineCarcinomaHumansSurvival pelvic exenteration primary recurrent cervical cancerSurvival rateRetrospective StudiesAgedNeoplasm StagingPelvic exenterationbusiness.industryCancerRetrospective cohort studyLymphatic Metastasimedicine.diseaseSurgeryPelvic ExenterationSettore MED/40 - GINECOLOGIA E OSTETRICIACervical cancerNeoplasm Recurrence LocalbusinessFollow-Up Studies
researchProduct

Suitability of non-glucose-carbohydrates for parenteral nutrition

1975

Postoperative parenteral nutrition can only be optimally effective if the characteristics of post-traumatic metabolism are taken into account. Two main possibilities are discussed for the carbohydrate component of parenteral nutrition during this phase: glucose with high doses of insulin or non-glucose carbohydrates (sugar substitutes) possibly in a suitable combination with glucose. The risks as well as the technical and organisational problems involved in the use of them are discussed and the authors prefer the second of the two alternatives. Possible side effects of non-glucose carbohydrates are pointed out and it is shown how these can be avoided by observing dose guidelines. So far a c…

Parenteral Nutritionmedicine.medical_treatmentBlood sugarPhysiologyFructoseCarbohydrate metabolismCritical Care and Intensive Care MedicineXylitolElectrolyteschemistry.chemical_compoundPregnancyDietary CarbohydratesmedicineHumansSugarXylitolOxalatesAdenine Nucleotidesbusiness.industryInsulinProteinsBilirubinGeneral MedicineMetabolismCarbohydrateLipid MetabolismUric AcidGlucoseParenteral nutritionBiochemistrychemistryLactatesFemaleParenteral Nutrition TotalbusinessEuropean Journal of Intensive Care Medicine
researchProduct